AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 81 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2022. The put-call ratio across all filers is 1.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $430,550 | -25.3% | 41,801 | +19.6% | 0.09% | -44.6% |
| Q2 2023 | $576,124 | +133.8% | 34,959 | +29.9% | 0.17% | +112.7% |
| Q1 2023 | $246,431 | +18.2% | 26,903 | -7.6% | 0.08% | +14.5% |
| Q4 2022 | $208,428 | +65.4% | 29,110 | +15.9% | 0.07% | +11.3% |
| Q3 2022 | $126,000 | +293.8% | 25,109 | +91.6% | 0.06% | +210.0% |
| Q2 2022 | $32,000 | – | 13,103 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |